
On April 30, 2026, HILE issued a delisting risk warning announcement, with its operating revenue plummeting to 188 million yuan and net profit turning negative. On the same day, the company announced the establishment of a subsidiary to take over all equity of seven dental chains, attempting to boost revenue through consolidation.
This move has drawn attention in the capital market: under the pressure of dual delisting red lines, dental assets are seen as a "quick-acting life-saving pill." However, after actual consolidation, the revenue of these clinics still falls far short of the critical threshold of 300 million yuan, leaving a significant gap.
The article further explores why A-share companies frequently choose dental assets as a lifeline tool and the risks and logic behind this trend. As regulatory rules tighten, can this "life-saving" strategy continue?……
This content is available to DentalGoodNews Pro members. Subscribe to read full article